Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

In the latest lawsuit, Apple was awarded $250 in damages – the statutory minimum, which was what the company sought in its ...

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

Apple is fighting a running legal battle with the health tech company Masimo over pulse oximetry technology and smartwatch design patents. A jury in a federal trial awarded Apple a paltry $250 ...

A federal jury has found that Masimo smartwatches infringed on two of Apple's smartwatches, according to media reports.

Masimo (NASDAQ: MASI) today announced that Vanderbilt University Medical Center (VUMC), a renowned healthcare facility in ...

Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO ...

Apple and Masimo are back in a California court this week for a bench ... the two companies in which the former alleges the ...

The modular, scalable monitoring platform offers a range of physiological measurements, including Masimo SET ® pulse oximetry, measure-on-inflation noninvasive blood pressure, continuous ...